38 research outputs found

    Impact of climate change on hydrology of Manjalar sub basin of river Vaigai in Tamil Nadu, India

    Get PDF
    This study evaluates the impacts of possible future climate change scenarios on the hydrology of the catchment area of the Manjalar sub basin of River Vaigai, Tamil Nadu, India carried out at the department of Soil and Water Conservation Engineering, Tamil Nadu Agricultural University during the period of 2011-2014 using Soiland Water Assessment Tool (SWAT). For the climate impact assessment the hydrological model was driven with output of bias corrected Earth System Models of the Coupled Model Intercomparison Project Phase 5 (CMIP5): HadGEM2. Climate scenarios were downscaled to a grid resolution of 0.22° x 0.22°. In this study RCP 4.5 and RCP 8.5 were included for future assessment with three future periods: 2012–2039, 2040–2069, and 2070–2098. The projected increase in maximum and minimum temperature for RCP 4.5 scenario is 0.8 to 2.3 ºC and 0.7 to 1.6 ºC and for RCP 8.5 scenario is 1.1 to 4.0 ºC and 1.0 to 3.1 ºC, respectively. Rainfall is projected to an increase between 9.2 to 15.2 per cent for RCP 4.5 scenario and an increase of 13.6 to 18.8 per cent for RCP 8.5 scenario during 21st century. The soil water storage and stream flow contribution to ground water are likely to increase in RCP 4.5 scenario and it would again decline for RCP 8.5 scenario during 21st century. The increase in annual rainfall evapotranspiration and surface runoff would be more in RCP 8.5 scenario compared to RCP 4.5 scenario. The possible changes projected by the study provide a useful input to effective planning of water resources of the study area

    Spatial and temporal analysis of drought in Manjalar sub-basin of Vaigai in Tamil Nadu using standardized precipitation index

    Get PDF
    Drought is universally acknowledged as a phenomenon associated with scarcity of water. Drought characterization is essential for drought management operations. Using drought indices is a pragmatic way to assimilate large amounts of data into quantitative information that can be used in applications such as drought forecasting, declaring drought levels, contingency planning and impact assessment. Using monthly mean precipitation data for a period of 1982-2012 from 12 raingauge stations in the Manjalar sub-basin of Vaigai using Standardized Precipitation Index (SPI) is produced for the drought analysis with the time scale of 3 months (SPI-3), 6 months (SPI-6) and 12 months (SPI-12) as they are applicable for agriculture and hydrological aspects, respectively. It was observed that the basin experienced frequent droughts for all months of the year. The highest percentage of occurrence of drought was observed in the month of July (15.3), May (15.4) and August (15.6) at SPI-3, SPI-6 and SPI-12 respectively. On an average we observed 32.6, 8.6, 5.6 and 2.3 percentages of drought occurred by mild, moderate, severe and extreme drought respectively with respect to SPI-12. The results showed that mild droughts occur most frequently and extreme droughts occur least frequently and the basin suffered severe drought during the year of 1985, 2004 and 2006. The central and south eastern parts of the basin had more potential sensitivity to the droughts in comparison with the other areas of the basin

    Hyperoxemia and excess oxygen use in early acute respiratory distress syndrome : Insights from the LUNG SAFE study

    Get PDF
    Publisher Copyright: © 2020 The Author(s). Copyright: Copyright 2020 Elsevier B.V., All rights reserved.Background: Concerns exist regarding the prevalence and impact of unnecessary oxygen use in patients with acute respiratory distress syndrome (ARDS). We examined this issue in patients with ARDS enrolled in the Large observational study to UNderstand the Global impact of Severe Acute respiratory FailurE (LUNG SAFE) study. Methods: In this secondary analysis of the LUNG SAFE study, we wished to determine the prevalence and the outcomes associated with hyperoxemia on day 1, sustained hyperoxemia, and excessive oxygen use in patients with early ARDS. Patients who fulfilled criteria of ARDS on day 1 and day 2 of acute hypoxemic respiratory failure were categorized based on the presence of hyperoxemia (PaO2 > 100 mmHg) on day 1, sustained (i.e., present on day 1 and day 2) hyperoxemia, or excessive oxygen use (FIO2 ≥ 0.60 during hyperoxemia). Results: Of 2005 patients that met the inclusion criteria, 131 (6.5%) were hypoxemic (PaO2 < 55 mmHg), 607 (30%) had hyperoxemia on day 1, and 250 (12%) had sustained hyperoxemia. Excess FIO2 use occurred in 400 (66%) out of 607 patients with hyperoxemia. Excess FIO2 use decreased from day 1 to day 2 of ARDS, with most hyperoxemic patients on day 2 receiving relatively low FIO2. Multivariate analyses found no independent relationship between day 1 hyperoxemia, sustained hyperoxemia, or excess FIO2 use and adverse clinical outcomes. Mortality was 42% in patients with excess FIO2 use, compared to 39% in a propensity-matched sample of normoxemic (PaO2 55-100 mmHg) patients (P = 0.47). Conclusions: Hyperoxemia and excess oxygen use are both prevalent in early ARDS but are most often non-sustained. No relationship was found between hyperoxemia or excessive oxygen use and patient outcome in this cohort. Trial registration: LUNG-SAFE is registered with ClinicalTrials.gov, NCT02010073publishersversionPeer reviewe

    Effect of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker initiation on organ support-free days in patients hospitalized with COVID-19

    Get PDF
    IMPORTANCE Overactivation of the renin-angiotensin system (RAS) may contribute to poor clinical outcomes in patients with COVID-19. Objective To determine whether angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) initiation improves outcomes in patients hospitalized for COVID-19. DESIGN, SETTING, AND PARTICIPANTS In an ongoing, adaptive platform randomized clinical trial, 721 critically ill and 58 non–critically ill hospitalized adults were randomized to receive an RAS inhibitor or control between March 16, 2021, and February 25, 2022, at 69 sites in 7 countries (final follow-up on June 1, 2022). INTERVENTIONS Patients were randomized to receive open-label initiation of an ACE inhibitor (n = 257), ARB (n = 248), ARB in combination with DMX-200 (a chemokine receptor-2 inhibitor; n = 10), or no RAS inhibitor (control; n = 264) for up to 10 days. MAIN OUTCOMES AND MEASURES The primary outcome was organ support–free days, a composite of hospital survival and days alive without cardiovascular or respiratory organ support through 21 days. The primary analysis was a bayesian cumulative logistic model. Odds ratios (ORs) greater than 1 represent improved outcomes. RESULTS On February 25, 2022, enrollment was discontinued due to safety concerns. Among 679 critically ill patients with available primary outcome data, the median age was 56 years and 239 participants (35.2%) were women. Median (IQR) organ support–free days among critically ill patients was 10 (–1 to 16) in the ACE inhibitor group (n = 231), 8 (–1 to 17) in the ARB group (n = 217), and 12 (0 to 17) in the control group (n = 231) (median adjusted odds ratios of 0.77 [95% bayesian credible interval, 0.58-1.06] for improvement for ACE inhibitor and 0.76 [95% credible interval, 0.56-1.05] for ARB compared with control). The posterior probabilities that ACE inhibitors and ARBs worsened organ support–free days compared with control were 94.9% and 95.4%, respectively. Hospital survival occurred in 166 of 231 critically ill participants (71.9%) in the ACE inhibitor group, 152 of 217 (70.0%) in the ARB group, and 182 of 231 (78.8%) in the control group (posterior probabilities that ACE inhibitor and ARB worsened hospital survival compared with control were 95.3% and 98.1%, respectively). CONCLUSIONS AND RELEVANCE In this trial, among critically ill adults with COVID-19, initiation of an ACE inhibitor or ARB did not improve, and likely worsened, clinical outcomes. TRIAL REGISTRATION ClinicalTrials.gov Identifier: NCT0273570

    Prevalence, associated factors and outcomes of pressure injuries in adult intensive care unit patients: the DecubICUs study

    Get PDF
    Funder: European Society of Intensive Care Medicine; doi: http://dx.doi.org/10.13039/501100013347Funder: Flemish Society for Critical Care NursesAbstract: Purpose: Intensive care unit (ICU) patients are particularly susceptible to developing pressure injuries. Epidemiologic data is however unavailable. We aimed to provide an international picture of the extent of pressure injuries and factors associated with ICU-acquired pressure injuries in adult ICU patients. Methods: International 1-day point-prevalence study; follow-up for outcome assessment until hospital discharge (maximum 12 weeks). Factors associated with ICU-acquired pressure injury and hospital mortality were assessed by generalised linear mixed-effects regression analysis. Results: Data from 13,254 patients in 1117 ICUs (90 countries) revealed 6747 pressure injuries; 3997 (59.2%) were ICU-acquired. Overall prevalence was 26.6% (95% confidence interval [CI] 25.9–27.3). ICU-acquired prevalence was 16.2% (95% CI 15.6–16.8). Sacrum (37%) and heels (19.5%) were most affected. Factors independently associated with ICU-acquired pressure injuries were older age, male sex, being underweight, emergency surgery, higher Simplified Acute Physiology Score II, Braden score 3 days, comorbidities (chronic obstructive pulmonary disease, immunodeficiency), organ support (renal replacement, mechanical ventilation on ICU admission), and being in a low or lower-middle income-economy. Gradually increasing associations with mortality were identified for increasing severity of pressure injury: stage I (odds ratio [OR] 1.5; 95% CI 1.2–1.8), stage II (OR 1.6; 95% CI 1.4–1.9), and stage III or worse (OR 2.8; 95% CI 2.3–3.3). Conclusion: Pressure injuries are common in adult ICU patients. ICU-acquired pressure injuries are associated with mainly intrinsic factors and mortality. Optimal care standards, increased awareness, appropriate resource allocation, and further research into optimal prevention are pivotal to tackle this important patient safety threat

    Comparative assessment-conventional manufacturing and remanufacturing of heavy vehicles drum brake shoe by life cycle assessment

    No full text
    Brake shoe remanufacturing is the best alternative mode of sustainable manufacturing when compared to conventional manufacturing”. This fact was evolved mainly due to the less remanufacturing costs and lesser processing steps than a conventionally manufactured brake shoe. The knowledge about the environmental impacts of conventionally manufactured brake shoe and remanufactured brake shoe is null. When searched for published study or articles of life cycle assessment about this automobile component there are no results relating to this study.Master of Science (Computer Integrated Manufacturing
    corecore